Clinical phenotypes in chronic obstructive pulmonary disease

被引:1
作者
Silva O, Rafael [1 ]
机构
[1] Univ Autonoma Chile, Hosp Reg Talca, Fac Ciencias Salud, Serv Med,Unidad Enfermedades Resp, Talca, Chile
关键词
Bronchitis; chronic; Phenotype; Pulmonary disease; chronic obstructive; AIR-FLOW OBSTRUCTION; TERM OXYGEN-THERAPY; COPD PHENOTYPES; MODERATE HYPOXEMIA; ECLIPSE COHORT; DETERMINANTS; ROFLUMILAST; MANAGEMENT; PROGNOSIS; EMPHYSEMA;
D O I
10.4067/S0034-98872012000700016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, that is defined by the degree of obstruction rendered by the forced expiratory volume in the first second (FEV1). This is a good parameter to define the severity of the disease but does not account for its heterogeneity and does not provide a good comprehension of its different clinical behaviors and responses to treatment. Therefore, the classification of these patients in different clinical phenotypes has been attempted, trying to search for common clinical behaviors and responses to treatment. These phenoptypes must be validated in longitudinal studies. Some of the phenotypes detected are COPD with chronic respiratory failure and responsive to home oxygen therapy, COPD with upper lobe emphysema and responsive to volume reduction surgery, COPD with frequent exacerbation behavior, COPD resembling bronchitis and responsive to Roflumilast and possibly, COPD with systemic involvement. Historically, the phenotypes pink puffer, blue bloater, chronic bronchitis were defined. In the next years, we will know if the definitions of these phenotypes will aid in the management of patients with COPD. (Rev Med Chile 2012; 140: 926-933).
引用
收藏
页码:926 / 933
页数:8
相关论文
共 45 条
  • [31] COPD and declining FEV1 -: Time to divide and conquer?
    Reilly, John J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) : 1616 - 1618
  • [32] The many "Small COPDs" - COPD should be an orphan disease
    Rennard, Stephen I.
    Vestbo, Jorgen
    [J]. CHEST, 2008, 134 (03) : 623 - 627
  • [33] EFFECTS OF PULMONARY REHABILITATION ON PHYSIOLOGICAL AND PSYCHOSOCIAL OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    RIES, AL
    KAPLAN, RM
    LIMBERG, TMK
    PREWITT, LM
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (11) : 823 - 832
  • [34] Arguments Against Inhaled Glucocorticoids in COPD by Phenotype Instead of by Severity
    Rodriguez-Roisin, Robert
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (06): : 269 - 270
  • [35] Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
    Schols, AMWJ
    Slangen, J
    Volovics, L
    Wouters, EFM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : 1791 - 1797
  • [36] Silva R, 2011, REV MED CHILE, V139, P550, DOI /S0034-98872011000400021
  • [37] Silva R, 2010, REV MED CHILE, V138, P1544, DOI /S0034-98872010001300012
  • [38] CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A DEFINITION AND IMPLICATIONS OF STRUCTURAL DETERMINANTS OF AIR-FLOW OBSTRUCTION FOR EPIDEMIOLOGY
    SNIDER, GL
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (03): : S3 - S8
  • [39] Sobradillo Patricia, 2010, Arch Bronconeumol, V46 Suppl 11, P8, DOI 10.1016/S0300-2896(10)70056-9
  • [40] Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort
    Spruit, Martijn A.
    Watkins, Michael L.
    Edwards, Lisa D.
    Vestbo, Jorgen
    Calverley, Peter M. A.
    Pinto-Plata, Victor
    Celli, Bartolome R.
    Tal-Singer, Ruth
    Wouters, Emiel F. M.
    [J]. RESPIRATORY MEDICINE, 2010, 104 (06) : 849 - 857